Form 4 for ACET Adicet Bio, Inc.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-24 · accession 0001193125-26-024755 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-27 | 2026-01-24 | ACET | Aftab Blake | CSO | F - Tax | $8.44 | -535 | 2,981 | -15% | -$4,515 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-24 | F | D | 535 | $8.44 | 2,981 | D | — | — | (F2) Reflects a 1-for-16 reverse stock split effected by the Issuer on December 30, 2025. |